$139.44
Near FV▼ -4.0% against the close used
Model range $57.79 – $229.85
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear$57.79Fair value$139.44Bull$229.85
FairClose
52-week traded range
52W low $138.0452W high $167.20
The 52-week range is measured from the stored price history, not estimated.
Trading close to the consensus fair value
Procter & Gamble closed at $145.27, 4.2% above the consensus fair value of $139.44 drawn from 9 valuation models.
Financial DNA score 55/100 — Good. P/E of 21.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
$124.04
-14.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$57.79
-60.2%
√(22.5 × EPS × BVPS)
EPS=6.62, BVPS=22.42 · outside Graham range (P/E 21.9, P/B 6.5) — asset-light, treat as a rough floor
P/E Fair Value
$132.40
-8.9%
EPS × 20x (sector P/E)
EPS=6.62, Sector P/E=20x
Peter Lynch (PEG)
$116.05
-20.1%
EPS × Growth% (PEG = 1 is fair)
EPS=6.62, g=17.5%
EV/EBITDA
$162.13
+11.6%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=22.91B
Dividend Discount (DDM)
$229.85
+58.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=4.26, r=10%, g=8%
Book Value (P/B)
$131.93
-9.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=22.42, ROE=29.5%, g=6%, r=10%
Reverse DCF
$145.27
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 8.4% | Historical: 17.5%
Margin of Safety
$78.56
-45.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=104.74, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.